Shanghai Medicilon Inc. (SHA:688202)
China
· Delayed Price · Currency is CNY 33.33
+3.13 (10.36%)
At close: May 29, 2025, 2:57 PM CST
Shanghai Medicilon Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -330.85 | -33.21 | 338.24 | 282.22 | 129.39 | Upgrade
|
| Depreciation & Amortization | 111.31 | 101.54 | 79.22 | 58.5 | 28.6 | Upgrade
|
| Other Amortization | 37.64 | 40.74 | 25.65 | 18.04 | 15.35 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.12 | 0.34 | 0.87 | 1.04 | 1.34 | Upgrade
|
| Asset Writedown & Restructuring Costs | 57.05 | 18.89 | 1.64 | 0.84 | 1.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -12.15 | -6.33 | -2.46 | - | -0.63 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 42.47 | 21.86 | 7.68 | 4.08 | Upgrade
|
| Other Operating Activities | 123.25 | 9.97 | -3.65 | 5.89 | 9.91 | Upgrade
|
| Change in Accounts Receivable | -17.22 | -60.36 | -434.33 | -104.96 | 57.76 | Upgrade
|
| Change in Inventory | 45.21 | -11.69 | -87.64 | -50.79 | -20.87 | Upgrade
|
| Change in Accounts Payable | 10.05 | -45.19 | 8.11 | 203.04 | -24.27 | Upgrade
|
| Change in Other Net Operating Assets | 1.96 | 2.76 | 15.59 | 19.28 | 0.14 | Upgrade
|
| Operating Cash Flow | -22.75 | 33.32 | -21.33 | 452.94 | 207.77 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 118.00% | 256.39% | Upgrade
|
| Capital Expenditures | -110.39 | -185.68 | -404.06 | -292.71 | -118.72 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.27 | - | 0.16 | 0.04 | Upgrade
|
| Cash Acquisitions | - | - | - | -7 | -324.52 | Upgrade
|
| Investment in Securities | 23.27 | -604.65 | 90 | -100 | 70.89 | Upgrade
|
| Other Investing Activities | -2.86 | 2.52 | 2.44 | - | 0.71 | Upgrade
|
| Investing Cash Flow | -89.97 | -787.55 | -311.62 | -399.55 | -371.6 | Upgrade
|
| Short-Term Debt Issued | - | 457.1 | 279 | - | - | Upgrade
|
| Long-Term Debt Issued | 320 | - | - | - | - | Upgrade
|
| Total Debt Issued | 320 | 457.1 | 279 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -337.02 | -50 | - | - | Upgrade
|
| Long-Term Debt Repaid | -356.08 | -20.72 | -20.19 | -13.9 | - | Upgrade
|
| Total Debt Repaid | -356.08 | -357.74 | -70.19 | -13.9 | - | Upgrade
|
| Net Debt Issued (Repaid) | -36.08 | 99.37 | 208.81 | -13.9 | - | Upgrade
|
| Issuance of Common Stock | - | 1,007 | 6.51 | 6.99 | - | Upgrade
|
| Repurchase of Common Stock | - | -19.99 | - | - | - | Upgrade
|
| Common Dividends Paid | -6.97 | -42.14 | -87.33 | -39.06 | - | Upgrade
|
| Other Financing Activities | -63.65 | -14.45 | -19.06 | -60 | -1.9 | Upgrade
|
| Financing Cash Flow | -106.71 | 1,030 | 108.94 | -105.97 | -1.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | 6.13 | -0.19 | 8.17 | -0.99 | -5.11 | Upgrade
|
| Net Cash Flow | -213.3 | 275.34 | -215.84 | -53.58 | -170.84 | Upgrade
|
| Free Cash Flow | -133.14 | -152.36 | -425.39 | 160.22 | 89.05 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 79.93% | - | Upgrade
|
| Free Cash Flow Margin | -12.83% | -11.16% | -25.64% | 13.73% | 13.37% | Upgrade
|
| Free Cash Flow Per Share | -0.99 | -1.19 | -3.50 | 1.32 | 0.73 | Upgrade
|
| Cash Income Tax Paid | -30.13 | -55.21 | 28.71 | -8.88 | -1.33 | Upgrade
|
| Levered Free Cash Flow | -170.59 | -159.98 | -583.36 | 14.51 | 21.43 | Upgrade
|
| Unlevered Free Cash Flow | -170.59 | -153.94 | -580.3 | 15.77 | 21.43 | Upgrade
|
| Change in Net Working Capital | 73.88 | 60.68 | 498.34 | -27.89 | -11.46 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.